Sensocure
Skoppum
About Sensocure
Sensocure is a company with major ambitions in the development and delivery of sensors for medical use. New medical technology developed in the company will be a breakthrough in real-time monitoring of body functions and early detection of organ damage. Insufficient blood supply to vital organs is the most common disease and cause of death in the Western world in terms of stroke, myocardial infarction, trauma, complications after surgery and a variety of other conditions. There is, therefore, a great need for diagnostics that can trigger early treatment in this area. Sensocure has developed IscAlert™, a body-implantable micro biosensor that can monitor blood flow in the human body organs. The sensor is easy to use and has applications eg in cardiac surgery, vascular surgery, transplant surgery and reconstructive surgery. The sensor technology is patented in many parts of the world and the first version of the sensor is CE marked and FDA approved.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Last round: Grant (Mar 2020)
- Website: sensocure.no
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Sensor
Social Profiles
Canonical: https://fsome.com/organization/sensocure-120184 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.